Meiragtx, Llc
Clinical trials sponsored by Meiragtx, Llc, explained in plain language.
-
Gene therapy for radiation dry mouth: long-term safety check underway
Disease control ENROLLING_BY_INVITATIONThis study follows adults who previously received a gene therapy (AAV2-hAQP1) for dry mouth caused by radiation treatment for head and neck cancers. Researchers will monitor participants for long-term side effects and how well the therapy continues to work. The goal is to see if …
Phase: PHASE2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New gene therapy aims to restore saliva in cancer survivors
Disease control OngoingThis study tests a single dose of gene therapy injected into a saliva gland to see if it can safely increase saliva production in people with dry mouth from past head and neck cancer radiation. About 17 adults will take part, and they will be followed for three years. The main go…
Phase: PHASE1 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated May 20, 2026 11:53 UTC